Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis

被引:35
|
作者
Jiménez-Jiménez, FJ
Hernánz, A
Medina-Acebrón, S
de Bustos, F
Zurdo, JM
Alonso, H
Puertas, I
Barcenilla, B
Sayed, Y
Cabrera-Valdivia, F
机构
[1] Univ Alcala de Henares, Hosp Univ Principe Asturias, Dept Neurol, Madrid, Spain
[2] Dept Biochem, Ciudad Sanitaria La Paz, Spain
[3] Hosp Nuestra Senora Prado, Dept Biochem, Toledo, Spain
来源
ACTA NEUROLOGICA SCANDINAVICA | 2005年 / 111卷 / 02期
关键词
amyotrophic lateral sclerosis; motoneuron disease; tau protein; cerebrospinal fluid;
D O I
10.1111/j.1600-0404.2005.00370.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective - To elucidate whether cerebrospinal fluid (CSF) concentrations of the microtubule-associated tau protein are related to the risk for sporadic amyotrophic lateral sclerosis (SALS). Patients/Methods - We measured tau concentrations in the CSF of 18 patients with SALS and 75 age- and sex-matched controls, using a specific ELISA method. Results - The mean CSF concentrations of tau protein did not differ significantly between SALS patient and control groups, were not influenced by the clinical form (spinal vs bulbar) of ALS, and were not correlated with age, age at onset, and duration of the disease. Conclusions - CSF tau concentrations are not a biochemical marker of ALS.
引用
收藏
页码:114 / 117
页数:4
相关论文
共 50 条
  • [31] LEAD CONCENTRATIONS IN BLOOD, PLASMA, ERYTHROCYTES, AND CEREBROSPINAL-FLUID IN AMYOTROPHIC LATERAL SCLEROSIS
    STOBER, T
    STELTE, W
    KUNZE, K
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 61 (01) : 21 - 26
  • [32] Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis: Relationship with disease course and activity
    Kosehasanogullari, Gorkem
    Ozakbas, Serkan
    Tufan, Serap
    Kaya, Derya
    Idiman, Egemen
    NEUROLOGY, 2008, 70 (11) : A381 - A381
  • [33] Cerebrospinal fluid biomarkers and their dysregulation in amyotrophic lateral sclerosis
    Tateishi, T.
    Yamasaki, R.
    Tanaka, M.
    Fukunaga, M.
    Kikuchi, H.
    Matsushita, T.
    Motomura, K.
    Ohyagi, Y.
    Kira, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S134 - S135
  • [34] Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
    Costa, Julia
    Gromicho, Marta
    Pronto-Laborinho, Ana
    Almeida, Conceicao
    Gomes, Ricardo A.
    Guerreiro, Ana C. L.
    Oliva, Abel
    Pinto, Susana
    de Carvalho, Mamede
    DIAGNOSTICS, 2021, 11 (07)
  • [35] Aberrant proteins in amyotrophic lateral sclerosis cerebrospinal fluid
    Kasarskis, EJ
    Haley, BE
    Pendergrass, JC
    ANNALS OF NEUROLOGY, 1997, 42 (03) : T236 - T236
  • [36] Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
    Chen, Yan
    Liu, Xiao-Hui
    Wu, Jian-Jun
    Ren, Hui-Ming
    Wang, Jian
    Ding, Zheng-Tong
    Jiang, Yu-Ping
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (06) : 2095 - 2106
  • [37] Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
    Thompson, Alexander G.
    Gray, Elizabeth
    Thezenas, Marie-Laetitia
    Charles, Philip D.
    Evetts, Samuel
    Hu, Michele T.
    Talbot, Kevin
    Fischer, Roman
    Kessler, Benedikt M.
    Turner, Martin R.
    ANNALS OF NEUROLOGY, 2018, 83 (02) : 258 - 268
  • [38] Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
    Brettschneider, J.
    Lehmensiek, V.
    Ahlert, T.
    Mogel, H.
    Sussmuth, S. D.
    Palm, C.
    Ludolph, A. C.
    Tumani, H.
    JOURNAL OF NEUROLOGY, 2007, 254 : 182 - 182
  • [39] Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis
    Brettschneider, Johannes
    Widl, Karin
    Schattauer, Dagmar
    Ludolph, Albert C.
    Tumani, Hayrettin
    NEUROSCIENCE LETTERS, 2007, 416 (03) : 257 - 260
  • [40] Cerebrospinal Fluid Biomarkers Panel in Amyotrophic Lateral Sclerosis
    Connor, James R.
    Mitchell, Ryan M.
    Simmons, Zachary
    NEUROLOGY, 2010, 74 (09) : A201 - A201